PBAC - 2023 in review

MAESTrO Database

18 January 2024 - In contrast to New Zealand, 2023 saw many new medicines listed on the PBS.

All up 13 new medicines were listed on the PBS last year; three of the 13 are new cancer medicines.

  • January - Faricimab (Vabsymo)
  • February - Opicapone (Omontys)
  • March - NIL
  • April - NIL
  • May - Asciminib hydrochloride (Scemblix), Vosiritide (Voxzogo)
  • June - NIL
  • July - Avatrombopag maleate (Doptelet), Finerenone (Kerendia)
  • August - Eptinezumab (Vyepti), Trabectedin (Yondelis)
  • September - Patiromer sorbitex calcium (Veltassa)
  • October - Bimekizumab (Bimzelx), Deucravacitinib (Sotyktu), Enfortumab vedotin (Padcev)
  • November -  Trastuzumab deruxtecan (Enhertu)
Michael Wonder

Posted by:

Michael Wonder